Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ITI Pharma & Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited12.729216043529.3853
Domestic EquitiesDivi's Laboratories Limited8.74573117120.1895
Domestic EquitiesApollo Hospitals Enterprise Limited6.12071926214.1296
Domestic EquitiesMax Healthcare Institute Limited6.080712072114.0374
Domestic EquitiesTorrent Pharmaceuticals Limited4.2623264469.8395
Domestic EquitiesAurobindo Pharma Limited4.0180756149.2756
Domestic EquitiesFortis Healthcare Limited3.6041905248.3201
Domestic EquitiesCohance Lifesciences Limited3.57611462718.2555
Domestic EquitiesLupin Limited3.2516360507.5063
Domestic EquitiesAster DM Healthcare Limited3.08821071347.1292
Domestic EquitiesAlkem Laboratories Limited3.0667124537.0795
Domestic EquitiesNeuland Laboratories Limited2.979839796.8789
Domestic EquitiesAbbott India Limited2.304717695.3203
Domestic EquitiesWockhardt Limited2.2028411765.0852
Domestic EquitiesCipla Limited1.9099287924.4089
Domestic EquitiesLaurus Labs Limited1.8482413694.2666
Domestic EquitiesGlenmark Pharmaceuticals Limited1.7954212964.1446
Domestic EquitiesHealthcare Global Enterprises Limited1.7483552614.0360
Domestic EquitiesDr. Reddy's Laboratories Limited1.7195315343.9695
Domestic EquitiesMankind Pharma Limited1.7109175463.9496
Domestic EquitiesSai Life Sciences Limited1.5169395953.5018
Domestic EquitiesIPCA Laboratories Limited1.4155224883.2677
Domestic EquitiesFDC Limited1.3675761793.1569
Domestic EquitiesOrchid Pharma Limited1.3086362583.0210
Domestic EquitiesSumitomo Chemical India Limited1.3077647813.0188
Domestic EquitiesBiocon Limited1.3063757063.0157
Domestic EquitiesSBI Life Insurance Company Limited1.2630148302.9156
Domestic EquitiesRainbow Childrens Medicare Limited1.1795201502.7229
Domestic EquitiesPiramal Pharma Limited1.06471312852.4578
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited1.025592132.3673
Domestic EquitiesOnesource Specialty Pharma Limited0.9948149892.2966
Domestic EquitiesStandard Glass Lining Technology Ltd0.97381401822.2481
Domestic EquitiesPoly Medicure Limited0.9054107792.0902
Domestic EquitiesCaplin Point Laboratories Limited0.8649104491.9966
Domestic EquitiesSupriya Lifescience Limited0.8215253701.8964
Domestic EquitiesLinde India Limited0.810231351.8703
Domestic EquitiesShilpa Medicare Limited0.7332495681.6927
Domestic EquitiesZydus Lifesciences Limited0.6856167921.5826
Domestic EquitiesAstraZeneca Pharma India Limited0.494112641.1406
Domestic EquitiesSyngene International Limited0.4819171591.1124
Total 97.2836 224.5791
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)2.7164 6.2709
Total 2.7164 6.2709
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.